Should You Sell Vir Biotechnology Inc (VIR) And Go Away This Year?

Vir Biotechnology Inc (NASDAQ:VIR) currently has a daily average trading volume of 1.01M but it saw 731497 shares traded in last market. With a market cap of 1.36B USD, the company’s current market price of $10.02 came falling about -0.60 while comparing to the previous closing price of $10.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $27.48 and as low as $7.61.

Taking a look at 20-day trading activity of Vir Biotechnology Inc (VIR) gives us an average price of $8.99, while its current price level is -63.54% below from 52-week high level whereas it is 31.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $9.57 while that of 200 days or SMA-200 reads an average of $10.02. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.09% during that period while stretching the period over a month that increases to 4.81%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 59.72 which implies that the stock is in neutral territory.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the JP Morgan which downgraded the stock as “Neutral” in its note to investors issued on January 29, 2024, recommending a price target of between $23 and $9 for it. BofA Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on September 08, 2023 while assigning a price target range of $23-$14. JP Morgan issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $35 and $34.

Over the week, VIR’s stock price is moving 5.03% up while it is 19.86% when we observe its performance for the past one month. Year-to-date it is -0.40% down and over the past year, the stock is showing a downside performance of -60.92%.

The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -1.45 beaten by the consensus estimate of -1.2 for the same. In next quarter, company is expected to be making quarterly sales of $7.64M as analysts are expecting the sales for current fiscal year at $80.46M and seeing the company making $38.53M in sales next year. Moreover, analysts are in estimates of $7.5M for current-quarter revenue.

Currently, Vir Biotechnology Inc’s total number of outstanding shares is 134.78M. Company’s return on investment (ROI) stands at -32.56% and return on equity (ROE) at -30.67%. Stock’s beta reads 0.49. Stock has a price to book (P/B) ratio of 0.88 while price to sale or P/S ratio amounts to 17.13. Its return on asset (ROA) is -24.19% on average.